Johnson & Johnson is trading 3.2% down today at €228.05 after investors digested a newly announced €5.5 billion settlement covering approximately 76,000 talc-litigation claims.
- The multi-billion euro payout aims to address a significant portion of the company's long-standing legal liabilities, though the scale of the settlement is weighing on the share price.
- Today's decline stands in contrast to a broadly positive backdrop for the healthcare sector, indicating that the specific legal overhang is the primary driver of the stock's weakness.